• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Vertex Pharmaceuticals

Spiral helical welded steel pipe
Biotech

Vertex drops Moderna-partnered inhaled CF candidate

Persistent lung inflammation issues doomed a next-gen cystic fibrosis candidate that was meant to help a group of patients not served by current meds.
Darren Incorvaia May 4, 2026 5:48pm
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

AbbVie inks $745M deal with China’s Haisco for two pain assets

Apr 13, 2026 9:48am
maze ladder

Maze stock plummets after potential 'best-in-class' ph. 2 data

Mar 25, 2026 10:57am
Racecar speeding down a track

Vertex races to FDA after phase 3 kidney disease data impress

Mar 10, 2026 6:20am
Parachute over a mountain in Switzerland

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Feb 27, 2026 8:30am
Martin Makary FDA Senate HELP confirmation

FDA reveals 2nd round of 'national priority' voucher winners

Nov 6, 2025 3:12pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings